reta + tesa is redundant as I said earlier, and MOTS-C + NAD+ are both hitting the same mitochondrial/insulin sensitivity pathway that reta already covers. GHK-Cu is the only one bringing something genuinely different to the table. Could keep it simple and save some money lol
yeah it does help with visceral fat — but that’s exactly the point, visceral fat means the deep intra-abdominal fat around your organs, and that’s already reta’s strongest suit via glucagon receptor activation (-42% VAT in phase 2 data). Tesamorelin was literally developed to target that same fat in HIV lipodystrophy patients. So you’d be paying for two compounds hitting the exact same tissue. It’s not additive, it’s just redundant
Not really — two compounds hitting the same receptor pathway don’t double the effect, you just hit a ceiling faster. It’s like taking two GLP-1s at once. The mechanism is the same, the target is the same, so you’re mostly just doubling the cost and the side effects, not the results
I were you I’d save the money and just keep reta + MOTS-C + GHK-Cu. Three compounds, three completely different mechanisms, fat loss, mitochondrial health, and tissue repair. Clean, no overlap, nothing wasted
Just needs to be taken at a low dose for a lot of people. Definitely curbed my appetite before I ramped up the dosage and it made me feel a lethargic I ended up just over eating to compensate
haha fair enough, HGH is definitely the real deal can’t argue with that. Happy it worked for you! For me personally I’d rather wait for an actual decline before jumping on steroids/HGH — still in my 20s so I want to make the most of my natural base while it’s still solid. Everyone’s timeline is different at the end of the day